GlassScriptPhysician profile
Jason S Hearn
NPI 1730367525
$389.66
in general payments reported to CMS, 2019-2025
9 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.25 · 2020: $25.32 · 2022: $39.53 · 2023: $47.27 · 2024: $74.51 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $301.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $198.51 | 2023-2025 | Citrefix, Prostep Mica, Ortholoc 3di Crosscheck |
| Paladin Technology Solutions | $32.34 | 2023 | |
| Kerecis Limited | $26.69 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $25.35 | 2025 | Stravix |
| Orthofix Medical, INC. | $25.32 | 2020 | |
| Zimmer Biomet Holdings, INC. | $25.29 | 2022 | |
| Paragon 28, INC. | $23.25 | 2019 | |
| Treace Medical Concepts, INC. | $18.67 | 2025 | |
| Integra Lifesciences Corporation | $14.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Hearn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.